| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-tocopheryl succinate: molecular pathways and structural requirements
* Institute for Prevention of Cardiovascular Diseases and Medical Policlinic, Ludwig-Maximilians-University, Munich, Germany;
Medical Center North, Vanderbilt University, Nashville, Tennessee, USA;
Flinders University of South Australia, Adelaide, South Australia, Australia;
§ Department of Pathology II, University Hospital, Linköping, Sweden;
¶ Biochemistry Department, INSERM, Toulouse, France; and
Faculty of Science, Charles University, Prague, Czech Republic
1Correspondence: Institute for Prevention of Cardiovascular Diseases, Pettenkoferstrasse 9, 80336 Munich, Germany. E-mail: jneuzil{at}klp.med.uni-muenchen.de or cweber{at}klp.med.uni-muenchen.de
The vitamin E analog 
-tocopheryl succinate (-TOS) can induce
apoptosis. We show that the proapoptotic activity of -TOS in
hematopoietic and cancer cell lines involves inhibition of protein
kinase C (PKC), since phorbol myristyl acetate prevented
-TOS-triggered apoptosis. More selective effectors indicated that
-TOS reduced PKC isotype activity by increasing protein
phosphatase 2A (PP2A) activity. The role of PKC inhibition in
-TOS-induced apoptosis was confirmed using antisense
oligonucleotides or PKC overexpression. Gain- or loss-of-function
bcl-2 mutants implied modulation of bcl-2 activity by PKC/PP2A as a
mitochondrial target of -TOS-induced proapoptotic signals.
Structural analogs revealed that -tocopheryl and succinyl moieties
are both required for maximizing these effects. In mice with colon
cancer xenografts, -TOS suppressed tumor growth by 80%. This
epitomizes cancer cell killing by a pharmacologically relevant compound
without known side effects.—Neuzil, J., Weber, T., Schröder, A.,
Lu, M., Ostermann, G., Gellert, N., Mayne, G. C., Olejnicka, B.,
Nègre-Salvayre, A., Stícha, M., Coffey, R. J.,
Weber, C. Induction of cancer cell apoptosis by -tocopheryl
succinate: molecular pathways and structural requirements.
Key Words: vitamin E succinate • protein kinase C • programmed cell death • colon cancer
This article has been cited by other articles:
|
|
 |
|
  P.-H. Huang, D. Wang, H.-C. Chuang, S. Wei, S. K. Kulp, and C.-S. Chen {alpha}-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis Carcinogenesis, July 1, 2009; 30(7): 1125 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-F. Dong, R. Freeman, J. Liu, R. Zobalova, A. Marin-Hernandez, M. Stantic, J. Rohlena, K. Valis, S. Rodriguez-Enriquez, B. Butcher, et al. Suppression of Tumor Growth In vivo by the Mitocan {alpha}-tocopheryl Succinate Requires Respiratory Complex II Clin. Cancer Res., March 1, 2009; 15(5): 1593 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ni, T. Mai, S.-T. Pang, I. Haque, K. Huang, M. A. DiMaggio, S. Xie, N. S. James, D. Kasi, S. R. Chemler, et al. In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-{alpha}-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer Clin. Cancer Res., February 1, 2009; 15(3): 898 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shim and T. E. Eling Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism Mol. Cancer Ther., April 1, 2008; 7(4): 961 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-F. Dong, E. Swettenham, J. Eliasson, X.-F. Wang, M. Gold, Y. Medunic, M. Stantic, P. Low, L. Prochazka, P. K. Witting, et al. Vitamin E Analogues Inhibit Angiogenesis by Selective Induction of Apoptosis in Proliferating Endothelial Cells: The Role of Oxidative Stress Cancer Res., December 15, 2007; 67(24): 11906 - 11913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Neuzil, M. Tomasetti, Y. Zhao, L.-F. Dong, M. Birringer, X.-F. Wang, P. Low, K. Wu, B. A. Salvatore, and S. J. Ralph Vitamin E Analogs, a Novel Group of "Mitocans," as Anticancer Agents: The Importance of Being Redox-Silent Mol. Pharmacol., May 1, 2007; 71(5): 1185 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-F. Wang, M. Birringer, L.-F. Dong, P. Veprek, P. Low, E. Swettenham, M. Stantic, L.-H. Yuan, R. Zobalova, K. Wu, et al. A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression Cancer Res., April 1, 2007; 67(7): 3337 - 3344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lee, M.-K. Choi, Y.-J. Lee, J.-L. Ku, K.-H. Kim, J.-S. Choi, and S.-J. Lim Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E2 production in human lung epithelial cells Carcinogenesis, November 1, 2006; 27(11): 2308 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Donapaty, S. Louis, E. Horvath, J. Kun, S. M. Sebti, and M. P. Malafa RRR-{alpha}-Tocopherol succinate down-regulates oncogenic Ras signaling. Mol. Cancer Ther., February 1, 2006; 5(2): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P. K. Witting, A. Procopio, and J. Neuzil {alpha}-Tocopheryl Succinate Inhibits Malignant Mesothelioma by Disrupting the Fibroblast Growth Factor Autocrine Loop: MECHANISM AND THE ROLE OF OXIDATIVE STRESS J. Biol. Chem., July 8, 2005; 280(27): 25369 - 25376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Tan, P. Sagoo, C. Chan, J. B. Yates, J. Campbell, S. C. Beutelspacher, B. M. J. Foxwell, G. Lombardi, and A. J. T. George Inhibition of NF-{kappa}B and Oxidative Pathways in Human Dendritic Cells by Antioxidative Vitamins Generates Regulatory T Cells J. Immunol., June 15, 2005; 174(12): 7633 - 7644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Zu, L. Hawthorn, and C. Ip Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by {alpha}-tocopheryl succinate in human prostate cancer cells Mol. Cancer Ther., January 1, 2005; 4(1): 43 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Prasad Multiple Dietary Antioxidants Enhance the Efficacy of Standard and Experimental Cancer Therapies and Decrease Their Toxicity Integr Cancer Ther, December 1, 2004; 3(4): 310 - 322. [Abstract] [PDF]
|
|
|
|
 |
|
 K. A. Lawson, K. Anderson, M. Simmons-Menchaca, J. Atkinson, L. Sun, B. G. Sanders, and K. Kline Comparison of Vitamin E Derivatives {alpha}-TEA and VES in Reduction of Mouse Mammary Tumor Burden and Metastasis Exp Biol Med, October 1, 2004; 229(9): 954 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Anderson, M. Simmons-Menchaca, K. A. Lawson, J. Atkinson, B. G. Sanders, and K. Kline Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, {alpha}-TEA Cancer Res., June 15, 2004; 64(12): 4263 - 4269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Albright, R. I. Salganik, and T. Van Dyke Dietary Depletion of Vitamin E and Vitamin A Inhibits Mammary Tumor Growth and Metastasis in Transgenic Mice J. Nutr., May 1, 2004; 134(5): 1139 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Zu and C. Ip Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells Cancer Res., October 15, 2003; 63(20): 6988 - 6995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dutta and S. K. Dutta Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review J. Am. Coll. Nutr., August 1, 2003; 22(4): 258 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Takahashi, K. Okumura, H. Matsui, Y. Saburi, H. Kamiya, K. Matsubara, T. Asai, M. Ito, and T. Murohara Impact of {alpha}-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol Cardiovasc Res, June 1, 2003; 58(3): 565 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yu, B. G. Sanders, and K. Kline RRR-{alpha}-Tocopheryl Succinate-induced Apoptosis of Human Breast Cancer Cells Involves Bax Translocation to Mitochondria Cancer Res., May 15, 2003; 63(10): 2483 - 2491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Lawson, K. Anderson, M. Menchaca, J. Atkinson, L. Sun, V. Knight, B. E. Gilbert, C. Conti, B. G. Sanders, and K. Kline Novel Vitamin E Analogue Decreases Syngeneic Mouse Mammary Tumor Burden and Reduces Lung Metastasis Mol. Cancer Ther., May 1, 2003; 2(5): 437 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Prasad, B. Kumar, X.-D. Yan, A. J. Hanson, and W. C. Cole {alpha}-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review J. Am. Coll. Nutr., April 1, 2003; 22(2): 108 - 117. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Brigelius-Flohe, F. J Kelly, J. T Salonen, J. Neuzil, J.-M. Zingg, and A. Azzi The European perspective on vitamin E: current knowledge and future research Am. J. Clinical Nutrition, October 1, 2002; 76(4): 703 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Kim, H.-G. Kim, C.-D. Oh, S.-G. Hwang, W.-K. Song, Y.-J. Yoo, S.-S. Kang, and J.-S. Chun p38 Kinase-dependent and -independent Inhibition of Protein Kinase C zeta and -alpha Regulates Nitric Oxide-induced Apoptosis and Dedifferentiation of Articular Chondrocytes J. Biol. Chem., August 9, 2002; 277(33): 30375 - 30381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, J. Ni, E. M. Messing, E. Chang, C.-R. Yang, and S. Yeh Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells PNAS, May 28, 2002; 99(11): 7408 - 7413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Deucher, T. Efimova, and R. L. Eckert Calcium-dependent Involucrin Expression Is Inversely Regulated by Protein Kinase C (PKC)alpha and PKCdelta J. Biol. Chem., May 3, 2002; 277(19): 17032 - 17040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Weber, M. Lu, L. Andera, H. Lahm, N. Gellert, M. W. Fariss, V. Korinek, W. Sattler, D. S. Ucker, A. Terman, et al. Vitamin E Succinate Is a Potent Novel Antineoplastic Agent with High Selectivity and Cooperativity with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (Apo2 Ligand) in Vivo Clin. Cancer Res., March 1, 2002; 8(3): 863 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. RICCIARELLI, J.-M. ZINGG, and A. AZZI Vitamin E: protective role of a Janus molecule FASEB J, November 1, 2001; 15(13): 2314 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Salganik The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population J. Am. Coll. Nutr., October 1, 2001; 20(90005): 464S - 472. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. You, W. Yu, B. G. Sanders, and K. Kline RRR-{alpha}-Tocopheryl Succinate Induces MDA-MB-435 and MCF-7 Human Breast Cancer Cells to Undergo Differentiation Cell Growth Differ., September 1, 2001; 12(9): 471 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yu, Q. Y. Liao, F. M. Hantash, B. G. Sanders, and K. Kline Activation of Extracellular Signal-regulated Kinase and c-Jun-NH2-terminal Kinase but not p38 Mitogen-activated Protein Kinases Is Required for RRR-{alpha}-Tocopheryl Succinate-induced Apoptosis of Human Breast Cancer Cells Cancer Res., September 1, 2001; 61(17): 6569 - 6576. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
